Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)
TYRA appoints urologic oncologist, Erik Goluboff, M.D., as SVP, Clinical Development to lead NMIBC- -First patient expected to be dosed in SURF302 in Q2 2025- CARLSBAD ...
The Mirror US on MSN56m
RuPaul gives touching tribute to The Vivienne at DragCon UK after death: 'Be free'
RuPaul has paid tribute to The Vivienne - who passed away in early January at the age of 32 - at the opening of DragCon UK ...